Name | Avotaciclib trihydrochloride |
---|
Description | Avotaciclib (BEY1107) trihydrochloride is a potent and orally active inhibitor of cyclin dependent kinase 1 (CDK1). Avotaciclib trihydrochloride can be used for the research of locally advanced or metastatic pancreatic cancer[1]. |
---|---|
Related Catalog | |
Target |
CDK1 |
References |
Molecular Formula | C13H14Cl3N7O |
---|---|
Molecular Weight | 390.66 |